What the nurses are up against when they go on strike should unite us all, writes Tarun Gidwani. Everywhere, the same corporations are hollowing out people’s ability to exercise their right to health.
In a lawsuit, global pharmaceutical companies acknowledged for the first time the extent to which Mexicans visiting the U.S. on short-term visas contribute to the world’s supply of blood plasma, Stefanie Dodt reports.
Provisions passed by the House last year that subjected insulin products to Medicare price negotiation and capped Medicare insulin copays at $35 per month have been left out of the latest draft of the bill.
Sam Pizzigati says the federal government should make use of the Defense Production Act and be ready to face the pharmaceutical giant in court.
There’s a lot of money to be made selling cures for the psychological wounds inflicted by the very system which enables that sale, writes Caitlin Johnstone.
The facility’s colonial mindset is an ever-present reminder that “aid is dead,” writes Suhail Omar.
Vijay Prashad calls out the Global North, Big Pharma and the capitalist logic of intellectual property rights.
The AstraZeneca jab was actually developed by scientists from a publicly-funded institution, writes Nick Dearden in a retort to comments by Boris Johnson.
“Instead of spending on innovation, Big Pharma is hoarding its money for salaries and dividends,” the report says, “all while swallowing smaller companies, thus making the marketplace far less competitive.”
Few people in poor countries will get vaccinated in 2021, making a mockery of the UN’s Sustainable Development Goals’ over-arching principle of “leaving no one behind,” the authors say.
